TOKAI PHARMACEUTICALS INC's ticker is TKAI and the CUSIP is 88907J107. A total of 56 filers reported holding TOKAI PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $17,000 | -15.0% | 20,403 | -1.4% | 0.00% | – |
| Q4 2016 | $20,000 | -37.5% | 20,703 | 0.0% | 0.00% | – |
| Q3 2016 | $32,000 | -72.2% | 20,703 | -0.5% | 0.00% | – |
| Q2 2016 | $115,000 | +1.8% | 20,803 | +3.0% | 0.00% | – |
| Q1 2016 | $113,000 | -26.1% | 20,203 | +14.9% | 0.00% | – |
| Q4 2015 | $153,000 | -14.0% | 17,580 | +2.1% | 0.00% | – |
| Q3 2015 | $178,000 | -22.6% | 17,218 | -0.6% | 0.00% | -100.0% |
| Q2 2015 | $230,000 | +85.5% | 17,318 | +57.4% | 0.00% | – |
| Q1 2015 | $124,000 | -23.5% | 11,000 | 0.0% | 0.00% | – |
| Q4 2014 | $162,000 | – | 11,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 511,010 | $2,815,665,000 | 0.61% |
| Perceptive Advisors | 661,041 | $3,642,000 | 0.25% |
| SABBY MANAGEMENT, LLC | 749,205 | $4,128,000 | 0.22% |
| Novo Holdings A/S | 128,993 | $711,000 | 0.08% |
| NJ State Employees Deferred Compensation Plan | 35,000 | $193,000 | 0.04% |
| Alyeska Investment Group, L.P. | 322,297 | $1,776,000 | 0.02% |
| PARADIGM ASSET MANAGEMENT CO LLC | 17,600 | $96,976,000 | 0.02% |
| ROPES WEALTH ADVISORS LLC | 6,000 | $33,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 100,000 | $551,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 3,262 | $17,000 | 0.00% |